Aspirin is probably one of the most well-known and oldest medicines in the world. As early as 1899, aspirin was one of the first drugs for sale in tablet form. After 120 years, by far the Bayer Group’s highest-selling drug, could the entire lifespan be seriously threatened? Even today, the Group generates a total turnover of € 975 million (2018) with this drug. Of this amount, €418 million will be in the Consumer Health products division and €557 million in the Pharmaceuticals division with the drug Aspirin Cardio.
But times are changing, because cannabis could be a serious alternative to aspirin and could also turn the entire painkiller market upside down. First scientists are already convinced that cannabis is more effective than aspirin for pain relief.
Cannabis has long been reduced to its intoxication, but it is now known to have significantly more positive properties. Cannabidiol (CBD) extracted from the female hemp plant have many positive aspects and are in no way intoxicating. In particular, the anti-inflammatory natural effect of the substance in combination with pain relief is a natural alternative to artificially produced preparations.
Especially chronic patients who complain of pain in combination with nausea would be better advised with a natural product, as it does not have unpleasant side effects like many other medications. Especially in long-term applications, these preparations also hit the liver and cause further discomfort.
Therefore, many people are looking for a natural alternative to alleviate their discomfort. In particular, when it comes to head, muscle or nerve pain, the anti-inflammatory agents of cannabidiol can provide a remedy.
CBD is already used extremely successfully as a supplement in pain therapy, especially by tumor patients or in palliative care. It is only a matter of time before these novel natural products outperform the established painkillers, especially if the patient is convinced of the better tolerability. Stomach problems or a blood thinning especially when taking aspirin, if it is not intended indicative, would be off the table.
You don’t have to be a prophet to realize that painkillers like aspirin, which have been on the market for 120 years and haven’t evolved significantly since then, will soon face serious competition from the cannabis plant family. This could sooner or later be a significant revenue guarantor in the Bayer Group.
Your Cannabisradar.info editorial team monitors and analyzes the cannabis sector for you. Benefit from our unique network built up over decades to brokers, analysts and industry experts!
The Cannabisradar-Team wishes you an nice day!